Work

Topical intranasal ioxaglate meglumine 39.3% and ioxaglate sodium 19.6% (Hexabrix) reduces the acute response to nasal challenge with allergen

Year: 2011

Type: article

Source: Journal of Allergy and Clinical Immunology

DOI: 10.1016/j.jaci.2011.02.024

Authors: Shilpa Vishwanath, Fuad M. Baroody, Mohamad R. Chaaban, Marcella deTineo, Kenneth H. Lasser, Elliot C. Lasser, Robert M. Naclerio

Institutions: University of Chicago, University of Chicago Medical Center, Kaiser Permanente, Kaiser Permanente San Diego Medical Center, University of California San Diego

Language: English

Topic: Allergic Rhinitis and Sensitization

Subfield: Immunology and Allergy

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2168563935

FWCI: 0.238

Cites: 4

Cited by: 4

Related to: 10